Cite
HARVARD Citation
Pilat, N. et al. (n.d.). Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study. European journal of surgical oncology. 41 (5), pp. 683-689. [Online].